YH-0623
Product Specifications
Target
OXPHOS|||Mitochondrial Metabolism|||PDGFR|||DNA/RNA Synthesis
Related Pathways
Cell Cycle/Checkpoint|||DNA Damage/DNA Repair|||Metabolism|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis
Bioactivity
YH-0623 is an orally active inhibitor of mitochondrial RNA polymerase (POLRMT) with an IC50 of 50.48 nM as determined by NanoBRET assay. It exhibits antiproliferative effects on 22Rv1 cells by downregulating mitochondrial gene expression. YH-0623 suppresses 22Rv1 cell growth, colony formation, and expression of proteins related to OXPHOS. Significant tumor growth inhibition was observed in a prostate cancer xenograft mouse model. YH-0623 is applicable for prostate cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6187771-01 0.1 mL
RIC8A (Resistance to Inhibitors of Cholinesterase 8 Homolog A (C. elegans), MGC104517, MGC131931, MGC148073, MGC148074, RIC8, synembryn) (PE)
Ask
View Details MBS6187771-02 5x 0.1 mL
RIC8A (Resistance to Inhibitors of Cholinesterase 8 Homolog A (C. elegans), MGC104517, MGC131931, MGC148073, MGC148074, RIC8, synembryn) (PE)
Ask
View Details 
135131-ML490 100 µL
UROD (Uroporphyrinogen Decarboxylase, UPD, URO-D) (MaxLight 490)
Ask
View Details